Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 65 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Brianna S.

United States

USD 65 /hr

PhD Immunologist | Nanotechnology Drug Delivery & Immunoassay Consultant | Immune Profiling • Flow Cytometry • ELISA

Profile Summary

I am a PhD-trained immunologist and pharmaceutical scientist with deep experience in translational research, immune assay development, and preclinical immunology. I help biotech companies, startups, and research teams design, optimize, and interpret immunology and cell-based assays, develop scientific reports, and translate complex data into clear, decision-ready insights. My work spans immune cell functional assays and biomarker evaluation, with hands-on expertise in multicolor flow cytometry, ELISA, multiplex assays, and primary immune cell systems. I have contributed to both academic and industry research programs, including preclinical therapeutic evaluation and assay reproducibility studies. I also bring specialized experience in nanotechnology-based drug delivery and biomaterial platforms, including the design and characterization of polymeric and nanoparticle systems for immune modulation and antigen delivery. My work integrates nanomedicine with immune assay evaluation to assess biological performance, immune activation, and translational potential. I’m known for being detail-driven, reliable, and highly communicative — delivering scientifically rigorous work on schedule. I can support short consulting projects, assay troubleshooting, data analysis, scientific writing, and technical documentation.

Subject Matter Expertise

• ☆ Materials Science & Engineering
• ☆ Nanotechnology & Nanomaterials
• ☆ Nanotechnology
• ☆ Biochemistry
• ☆ Immunoassay
• ☆ Biochemical Assays
• ☆ Basic Immunology
• ☆ Adjuvant & Antigen Research
• ☆ Biotechnology & Bioengineering
• ☆ Nanobiotechnology

Services

• Research

Research Scientific and Technical Research

Work Experience

Post Doctoral Fellow

University of Maryland, Baltimore

- Present

Postdoctoral Fellow

University of Maryland Baltimore

June 2024 - June 2025

Education

Ph.D. (Pharmaceutical Sciences )

University of Maryland, Baltimore

- Present

PhD in Pharmaceutical Sciences

University of Maryland, Baltimore - United States

August 2018 - April 2024

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Brianna L. Scotland, Shruti Dharmaraj, Andrea L. Cottingham, Nhu Truong, Svetlana P. Chapoval, Achsah D. Keegan, Ryan M. Pearson (2024). Impact of antigen loading in tolerogenic nanoparticles to mitigate Th2-mediated allergic lung inflammation . Drug Delivery and Translational Research.

Brianna L. Scotland, Jacob R. Shaw, Shruti Dharmaraj, Nicholas Caprio, Andrea L. Cottingham, Jackline Joy Martín Lasola, Junsik J. Sung, Ryan M. Pearson (2023). Cell and biomaterial delivery strategies to induce immune tolerance . Advanced Drug Delivery Reviews.

Brianna L. Scotland, Andrea L. Cottingham, Jackline Joy M. Lasola, Stephen W. Hoag, Ryan M. Pearson (2023). Development of Protein–Polymer Conjugate Nanoparticles for Modulation of Dendritic Cell Phenotype and Antigen-Specific CD4 T Cell Responses . ACS Applied Polymer Materials.

Michael H. Zhang, Brianna L. Scotland, Yun Jiao, Emily M. Slaby, Nhu Truong, Andrea L. Cottingham, Georgina Stephanie, Gregory L. Szeto, Ryan M. Pearson(2023). Lipid–Polymer Hybrid Nanoparticles Utilize B Cells and Dendritic Cells to Elicit Distinct Antigen-Specific CD4⁺ and CD8⁺ T Cell Responses . ACS Applied Bio Materials. American Chemical Society ({ACS})

Jackline Joy Martín Lasola, Andrea L. Cottingham, Brianna L. Scotland, Nhu Truong, Charles C. Hong, Paul Shapiro, Ryan M. Pearson(2021). Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK . Pharmaceutics. 13. (11). p. 1841. {MDPI} {AG}

Jackline Joy Martín Lasola, Andrea L. Cottingham, Brianna L. Scotland, Nhu Truong, Charles C. Hong, Paul Shapiro, Ryan M. Pearson (2021). Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK . Pharmaceutics.